Posts by MVision Team

AI and Radiotherapy in Bangladesh: Reflections from BICC 2025
By Norina Predescu, MVision AI Radiation Oncologist Earlier this year, I had the privilege of travelling to Bangladesh together with MVision AI’s CEO, Mahmudul Hasan,…
MVision AI’s Workspace+ Receives CE Mark Class IIa Certification
Helsinki, October 21, 2025 – MVision AI, a leading provider of vendor-neutral AI solutions for radiotherapy, proudly announces that its Workspace+ platform has received CE…
Comparative Algorithm Testing in Sweden for Thorax Organs at Risk
AI is increasingly implemented in multiple fields, including medicine. In radiation oncology, organizations like MVision AI are contributing to the development of advanced solutions that…
MVision AI Appoints Rachel Buckingham as Customer Success Manager
Helsinki, October 2025 – MVision AI is pleased to announce the appointment of Rachel Buckingham as Customer Success Manager, strengthening our customer partnerships and support…
MVision AI Working on Agreement to Offer Contour+ Access™ with Philips CT Simulators
Helsinki — September 28, 2025 — MVision AI today announced that it is working with Royal Philips on an agreement to offer MVision AI’s Contour+…
MVision AI Founder Mahmudul Hasan Returns as CEO to Lead Next Phase of Growth
Helsinki, September 2025 – MVision AI, a pioneer in AI solutions for radiotherapy, today announced that Mahmudul Hasan, the company’s Founder and Executive Director, is…
MVision AI Announces Distribution Partnership with Meditest in France
Helsinki, September 2025 — MVision AI, a global provider of AI-powered solutions for radiotherapy planning, has signed a distribution agreement with Meditest, a French specialist…
MVision AI’s Dose+ Receives FDA 510(k) Clearance for Clinical Use in the United States
Helsinki, September 2025 – MVision AI is proud to announce that Dose+, its AI-powered solution for dose prediction and personalised radiotherapy treatment planning, has received…
MVision AI’s Dose+ Receives Market Approval in Australia
Helsinki, August 2025 — MVision AI announces that Dose+ has received market approval for the Australian market from the Therapeutic Goods Administration (TGA). The product…
Multi-Institutional Study Demonstrates Time and Consistency Benefits of MVision Contour+ for Head and Neck Radiotherapy
MVision Contour+ improves consistency and saves time, according to HARMONY, a multi-institutional international study. The research was conducted in seven clinics from four countries and…